KPIs & Operating Metrics(New)

Balance Sheet

Cash Flow Statement

Acquisitions Capital Expenditures Capital Expenditures Cash from Financing Activities Cash from Financing Activities Cash from Investing Activities Cash from Investing Activities Cash from Operations Cash from Operations Change in Account Payables Change in Account Payables Change in Accured Expenses Change in Accured Expenses Change in Acquisitions & Divestments Change in Acquisitions & Divestments Change in Cash Change in Inventory Change in Inventory Change in Receivables Change in Receivables Deferred Taxes Depreciation & Amortization (CF)Depreciation & Amortization (CF)Divestments Dividends Paid - Common Dividends Paid - Common Exchange Rate Effect Exchange Rate Effect Free Cash Flow Free Cash Flow Gains from Investment Securities Gains from Investment Securities Long-Term Debt Issuances Long-Term Debt Repayments Net Cash Flow Net Cash Flow Net Income Non-cash Items Non-cash Items Other Working Capital Changes Other Working Capital Changes Other financing activities Other financing activities Sales of Property, Plant and Equipment Sales of Property, Plant and Equipment Share-based Compensation Share-based Compensation Shares Repurchased Short-Term Debt issuances

Daily Values

Growth Metrics

Others

Procter & Gamble (PG) Asset Writedowns and Impairment (2016 - 2023)

Procter & Gamble has reported Asset Writedowns and Impairment over the past 7 years, most recently at $1.3 billion for Q4 2023.

Quarterly Asset Writedowns and Impairment changed N/A to $1.3 billion in Q4 2023 from the year-ago period, while the trailing twelve-month figure was $1.3 billion through Dec 2024, changed 0.0% year-over-year, with the annual reading at $1.3 billion for FY2024, N/A changed from the prior year.
Asset Writedowns and Impairment was $1.3 billion for Q4 2023 at Procter & Gamble, up from -$48.0 million in the prior quarter.
Over five years, Asset Writedowns and Impairment peaked at $1.3 billion in Q4 2023 and troughed at $1.3 billion in Q4 2023.